KILITCH.BO

Kilitch Drugs (India) Limited

HealthcareDrug Manufacturers - Specialty & GenericININRPeers →Country macro →

$183.00

Jun 18, 2026

AI Brief

Market cap

$6.5B

52w range

—

P / E

—

EPS · FY 2026

$8.91

Volume

—

Revenue · FY 2026

$2.35B

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on Kilitch Drugs (India) Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$183.00

Change

+11.69%

Period high

$189.25

Period low

$127.55

Period start

$163.852026-02-01

Through 2026-06-18

Fair value

Football field →

Weighted blend

$194.92

— vs spot

Recommendation

n/a

3 of 3 methods

Method spread

0bull0bear

±5% threshold

Candlestick · 1Y

Open in chart workstation →

KILITCH.BO

183.00+11.69%

H 202.50L 121.10MA50 162.02MA200 —Avg vol 7K

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Communication Services
+1.85%
Utilities
+1.35%
Consumer Cyclical
+0.30%
Energy
-0.45%
Industrials
-0.48%
Basic Materials
-0.66%
Financial Services
-0.67%
Technology
-0.95%
Healthcare
-1.51%
Consumer Defensive
-1.52%
Real Estate
-2.19%

Top industries (issuer's industry highlighted)

No industry data returned.

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for KILITCH.BO.

Peers

No peer list available for KILITCH.BO.

Total assets

$4.58B

Total debt

$887.09M

Cash & equiv

$167.76M

Operating CF

$189.43M

Free cash flow

-$805.64M

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$2.35B	$329.77M	$301.66M	$8.91	+12.81%